TY - JOUR
AU - Wittner, Murray
AB - JID 1992;166 (July) Correspondence cation des manifestations neurologiques associees au HTLV-I. Presse primer pairs in highly conserved regions of viral genome. Third, Med 1991;20:661. the exquisite sensitivity of PCR is such that contamination of 4. Ehrlich GO. Glaser JB. Lavigne K. et al. Prevalence of human 'f-cell laboratory or nonspecific amplifications can lead to false-posi­ leukemia/lymphoma virus (HTL V) type II infection among high-risk tive results. Our preliminary results do not support the existence individuals: type specific identification of HTLVs by polymerase of frequent HTLV-I and -II infection in French anti-HTLV-Ij chain reaction. Blood 1989;74: 1658-64. II-negative IVDUs. Serologic tests used for diagnosis ofHTLV-I 5. Mariotti M. Lefrere JJ, Noel B, et al. DNA amplification of HIV-I in and -II infection do not underestimate the prevalence of infec­ seropositive individuals and in seronegative at-risk individuals. AIDS tion. 1990;4:633-7. 6. Lemaire 1M. Coste J, Barin F. Courouce AM, et al. Etude epidemiologique des anticorps anti HTLV-lfII chez les donneurs de Francois Lefrere, Eric Wattel, Martine Mariotti, sang en France metropolitaine. Rev Fr Transfus Hemobiol Frantz Agis, Emmanuel Gordien, and Jean-Jacques Lefrere 1991;34:21-34. Laboratoire de Biologie Moleculaire, Institut National 7. Lee H. Swanson P. Shorty VS. Zack JA. Rosenblatt JD. Chen 
TI - Identification of Toxoplasma gondii Bradyzoite-Specific Monoclonal Antibodies
JF - The Journal of Infectious Diseases
DO - 10.1093/infdis/166.1.213
DA - 1992-07-01
UR - https://www.deepdyve.com/lp/oxford-university-press/identification-of-toxoplasma-gondii-bradyzoite-specific-monoclonal-pV0Js6X0sA
SP - 213
EP - 215
VL - 166
IS - 1
DP - DeepDyve
ER -